Disc Medicine IRON
NASDAQ IRON
$79.23 -0.14 (-0.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Disc Medicine (IRON) Change in Account Payables (2020 - 2026)

Disc Medicine (IRON) posted quarterly Change in Account Payables of -$4.9 million for Q2 2026, down 1432.4% year-over-year from $369183.8 in Q2 2025, and down 279.46% quarter-over-quarter from $2.7 million in Q1 2026.

Analysis

Disc Medicine (IRON) Change in Account Payables (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Change in Account Payables for 7 consecutive years, with -$4.9 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Account Payables fell 1432.4% year-over-year to -$4.9 million; the TTM figure through Jun 2026 stood at $490000.0 (down 72.0% YoY), while the FY2025 annual figure was $1.1 million, up 122.86% from the prior year.
  • Change in Account Payables fell to -$4.9 million in Q2 2026 per IRON's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $4.4 million in Q4 2024 and bottomed at -$10.8 million in Q1 2023.
  • Historically, Change in Account Payables has averaged -$500222.2 across 5 years, with a median of -$362000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Change in Account Payables jumped 5463.51% — and 2026, when it tumbled 1432.4%.
  • Disc Medicine's Change in Account Payables stood at -$74000.0 in 2022, then surged by 5463.51% to $4.0 million in 2023, then advanced by 10.73% to $4.4 million in 2024, then sank by 60.18% to $1.8 million in 2025, then plunged by 381.09% to -$4.9 million in 2026.
  • Business Quant data shows IRON's Change in Account Payables at -$4.9 million in Q2 2026, $2.7 million in Q1 2026, and $1.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Disc Medicine 3.06 Bn 3.06 Bn - -4.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.92 Mn
Mar 31, 2026 2.74 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 918,000.00
Jun 30, 2025 -321,000.00
Mar 31, 2025 -1.28 Mn
Dec 31, 2024 4.40 Mn
Sep 30, 2024 -1.05 Mn
Jun 30, 2024 -669,000.00
Mar 31, 2024 -7.36 Mn
Dec 31, 2023 3.97 Mn
Sep 30, 2023 3.77 Mn
Jun 30, 2023 -726,000.00
Mar 31, 2023 -10.75 Mn
Dec 31, 2022 -74,000.00
Sep 30, 2022 -403,000.00
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -982,000.00
Dec 31, 2021 1.77 Mn
Sep 30, 2021 -501,000.00